Drug Of Abuse Testing Market Growth Outlook: Why Analysts Expect Continued Expansion
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Drug Of Abuse Testing Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The drug of abuse testing market has demonstrated robust expansion over recent years. Its size is anticipated to rise from $7.16 billion in 2025 to $7.64 billion in 2026, indicating a compound annual growth rate (CAGR) of 6.7%. The historical progression of this market can be attributed to the reliance on manual laboratory confirmation methods, the broadened scope of workplace drug screening regulations, the increase in forensic toxicology laboratories, the advent of immunoassay testing techniques, and growing awareness programs concerning the opioid crisis.
The drug of abuse testing market is projected to experience substantial growth in the coming years, reaching $9.97 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.9%. This anticipated expansion during the forecast period is due to several factors, including an increase in substance abuse monitoring initiatives, broader mandatory workplace testing policies, greater use of rapid point-of-care testing kits, a surge in demand from forensic and criminal investigations, and the proliferation of global rehabilitation and treatment programs. Key trends anticipated during this period encompass the adoption of point-of-care rapid drug screening, an expansion in workplace drug testing compliance, increased specialization in forensic toxicology laboratories, the development of sports and athletic anti-doping testing programs, and refined emergency department toxicology screening protocols.
Get A Free Sample Report With In-Depth Market Insights:
Drug Of Abuse Testing Market Demand Drivers Opening New Revenue Streams
The increasing occurrence of substance abuse and addiction is anticipated to drive the expansion of the drug of abuse testing market in the future. Substance abuse and addiction describe the detrimental or dangerous consumption of psychoactive substances, encompassing illegal drugs and prescribed medicines, which can negatively affect health, safety, and social or legal functions. The frequency of substance abuse and addiction is rising due to more straightforward access to drugs and evolving societal behaviors that either normalize or boost drug consumption. Drug of abuse testing aids in confronting substance abuse and addiction by facilitating the prompt identification of drug use, directing timely medical interventions, overseeing recovery progress, and bolstering public health initiatives aimed at lessening the adverse effects of substance misuse. For instance, in December 2025, according to the Addiction Policy Forum, a US-based non-profit organization, Of the 48.4 million people with a substance use disorder, 27.9 million had an alcohol use disorder and 28.2 million had a drug use disorder in 2024. Consequently, the growing prevalence of substance abuse and addiction is propelling the drug of abuse testing market’s growth.
Drug Of Abuse Testing Market Segment Outlook: Which Categories Are Growing Fastest?
The drug of abuse testing market covered in this report is segmented –
1) By Product And Service: Rapid Testing Devices, Urine Testing Devices, Oral Fluid Saliva Testing Devices, Analyzers, Consumables, Laboratory Services
2) By Sample Type: Urine, Oral Fluid Saliva, Hair, Breath, Blood, Sweat
3) By Drug Type: Psychostimulants, Narcotics, Cannabinoids, Sedatives, Other Drug Types
4) By Technique Type: Immunoassay, Chromatography
5) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users
Subsegments:
1) By Rapid Testing Devices: Point Of Care Testing Kits, Home Testing Kits, Immunoassay Rapid Test Strips, Portable Screening Devices
2) By Urine Testing Devices: Urine Collection Kits, Urine Screening Test Strips, Cup Based Testing Devices, Laboratory Urine Test Kits
3) By Oral Fluid Saliva Testing Devices: Saliva Collection Kits, Oral Fluid Screening Devices, Disposable Oral Swab Kits, Portable Saliva Analyzers
4) By Analyzers: Immunoassay Analyzers, Chromatography Analyzers, Mass Spectrometry Analyzers, Point Of Care Analyzers
5) By Consumables: Test Strips And Reagents, Sample Collection Tubes, Control And Calibration Kits, Disposable Pipettes And Swabs
6) By Laboratory Services: Drug Screening Services, Confirmatory Testing Services, Sample Collection And Processing Services, Data Reporting And Analysis Services
Drug Of Abuse Testing Market Trends Powering Strategic Industry Growth
Leading companies in the drug of abuse testing market are concentrating on developing advanced products, such as multi-analyte clinical drug testing panels, to enable faster, more accurate, and comprehensive simultaneous detection of multiple drugs. These multi-analyte clinical drug testing panels are devices designed to detect several drugs of abuse from a single sample concurrently, aiding healthcare and forensic professionals in quickly identifying substance use with high accuracy and efficiency compared to traditional single-drug tests. For instance, in February 2026, Randox USA, a U. S.-based diagnostics company, secured 510(k) clearance from the U. S. Food and Drug Administration (FDA) for its Evidence MultiSTAT, an innovative multi-analyte clinical drug testing panel. This device is a fully automated, cartridge-based analyzer that utilizes patented Biochip Technology to simultaneously detect 15 drugs of abuse from urine in just 21 minutes. It features a straightforward three-step testing process, pre-filled reagent cartridges, and delivers highly accurate results comparable to confirmatory laboratory methods. The Evidence MultiSTAT covers a broad array of drug classes, including opioids, fentanyl, methamphetamine, cocaine, benzodiazepines, and cannabinoids, making it suitable for application in hospital laboratories, emergency departments, pain management clinics, behavioral health centers, and forensic settings. This technology significantly improves efficiency, reduces human error, and provides rapid, reliable results when compared to traditional single-analyte tests.
Drug Of Abuse Testing Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the drug of abuse testing market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Drägerwerk AG & Co. KGaA, Shimadzu Corporation, Bio-Rad Laboratories Inc., OraSure Technologies, Clinical Reference Laboratory (CRL) Inc., Legacy Medical Services, Intoximeters Inc., Cordant Health Solutions, DrugScan, Premier Biotech Inc., UCP Biosciences, American Screening Corporation Inc., SureHire Inc.
View The Full Drug Of Abuse Testing Market Report:
Drug Of Abuse Testing Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the drug of abuse testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug of abuse testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
